Get in touch

We respond to most inquiries within two business days.

Clinical trial:
volunteer@parleyneuro.com
Montana clinicians:
clinicians@parleyneuro.com
Partnerships & press:
sam@parleyneuro.com
Scientific inquiries:
achim@parleyneuro.com

Parley Neurotech, 3000 Lawrence Street, Denver, CO 80205

I'm reaching out about…
Clinical trial
Partnerships
Press or media
General inquiry
Becoming a Montana provider
For your privacy, if you are interested in the trial or treatment please do not include any personally identifiable or medical information in your message. Applications for the trial are available here.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
The ScienceFor CliniciansAboutNewsContactPrivacy PolicyTerms and Conditions

Parley Neurotech's experimental therapy has not yet been reviewed by the FDA. It will soon be accessible in Montana under the soon to be implemented right to try law, state Senate Bill 5353. Informed and consenting adults may request this experimental treatment in Montana from their clinician prior to FDA review of efficacy claims. Safety of the small molecule component of Parley Neurotech's combination therapy, clemastine fumarate at a lower dosage, has been approved by the FDA since 1977.